Expression of ezrin is associated with invasion and dedifferentiation of hepatitis B related hepatocellular carcinoma

BMC Cancer

Volumn 9, Issue , 2009, Pages

  Yeh, Chun Nan ^a   Pang, See Tong ^a   Chen, Tsung Wen ^a   Wu, Ren Ching ^a   Weng, Wen Hui ^b   Chen, Miin Fu ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b NATIONAL TAIPEI UNIVERSITY OF TECHNOLOGY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; DNA; EZRIN; MUTANT PROTEIN; TYROSINE; CYTOSKELETON PROTEIN;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER RECURRENCE; CANCER SURVIVAL; CARCINOMA CELL; CELL DEDIFFERENTIATION; CELL DIFFERENTIATION; CONTROLLED STUDY; FEMALE; GENE CONSTRUCT; GENE FUNCTION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GENETIC TRANSFECTION; HEPATITIS B; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; PROTEIN SECRETION; TREATMENT RESPONSE; TUMOR VOLUME; VASCULAR DISEASE; WILD TYPE; BIOSYNTHESIS; GENE EXPRESSION REGULATION; LIVER TUMOR; METABOLISM; MIDDLE AGED; MUTATION; TREATMENT OUTCOME;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CELL DIFFERENTIATION; CYTOSKELETAL PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE EXPRESSION REGULATION, VIRAL; HEPATECTOMY; HEPATITIS B; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MUTATION; NEOPLASM INVASIVENESS; TREATMENT OUTCOME;

EID: 68349122458     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-9-233     Document Type: Article

References (27)

1. Department of Health, Executive Yuan, Republic of China Annual report of cancer registration 2006
2. Beasley RP Hwang LY Lin CC et al Hepatocellular and hepatitis B virus: A prospective study of 22707 men in Taiwan Lancet 1981, 2:1129-1133 10.1016/S0140-6736(81)90585-7 6118576
3. Liaw YF Lin DY Chen TL et al Natural course after the development of cirrhosis in patients with chronic type B hepatitis: A prospective study Liver 1989, 9:235-241 2770436
4. Chen DS From hepatitis to hepatoma: Lessons from type B viral hepatitis Science 1993, 232:369-370 10.1126/science.8211155
5. Chen MF Jeng LB Lee WC Surgical results in patients with hepatitis virus-related hepatocellular carcinoma in Taiwan World J Surg 2002, 26(6):742-747 10.1007/s00268-002-6143-9 12053231
6. Yu Y Khan J Khanna C Helman L Meltzer PS Merlino G Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators Nat Med 2004, 10:175-181 10.1038/nm966 14704789
7. Khanna C Wan X Bose S Cassaday R Olomu O Mendoza A Yeung C Gorlick R Hewitt SM Helman LJ The membrane - cytoskeleton linker ezrin is necessary for osteosarcoma metastasis Nat Med 2004, 10:182-186 10.1038/ nm982 14704791
8. Bretscher A Edwards K Fehon RG ERM proteins and merlin: Integrators at the cell cortex Nat Rev Mol Cell Biol 2002, 3:586-599 10.1038/nrm882 12154370
9. Takeuchi K Kawashima A Nagafuchi A Tsukita S Structural diversity of band 4.1 superfamily members J Cell Sci 1994, 107:1921-1928 7983158
10. Brown KL Birkenhead D Lai JC Li L Li R Johnson P Regulation of hyaluronan binding by F-actin and colocalization of CD44 and phosphorylated ezrin/radixin/moesin (ERM) proteins in myeloid cells Exp Cell Res 2005, 15; 303(2):400-14 10.1016/j.yexcr.2004.10.002
11. Yonemura S Hirao M Doi Y Ezrin/radixin/moesin (ERM) proteins bind to a positively charged amino acid cluster in the juxta-membrane cytoplasmic domain of CD44, CD43, and ICAM-2 J Cell Biol 1998 23; 140 4 885 95 10.1083/jcb.140.4.885
12. Heiska L Alfthan K Gronholm M Vilja P Vaheri A Carpen O Association of ezrin with intercellular adhesion molecule-1 and -2 (ICAM-1 and ICAM-2). Regulation by phosphatidylinositol 4, 5-bisphosphate J Biol Chem 1998, 21; 273(34):21893-900 10.1074/jbc.273.34.21893
13. Gautreau A Poullet P Louvard D Arpin M Ezrin, a plasma membrane-microfilament linker, signals cell survival through the phosphatidylinositol 3-kinase/Akt pathway Proc Natl Acad Sci USA 1999 22; 96(13):7300-5 10.1073/pnas.96.13.7300
14. Pang ST Fang X Valdman A Norstedt G Pousette A Egevad L Ekman P Expression of ezrin in prostatic intraepithelial neoplasia Urology 2004, 63(3):609-12 10.1016/j.urology.2003.09.068 15028477
15. Valdman A Fang X Pang ST Nilsson B Ekman P Egevad L Ezrin expression in prostate cancer and benign prostatic tissue Eur Urol 2005, 48(5):852-7 10.1016/j.eururo.2005.03.013 16230228
16. Bohling T Turunen O Jaaskelainen J Ezrin et al expression in stromal cells of capillary hemangioblastoma. An immunohistochemical survey of brain tumors Am J Pathol 1996, 148(2):367-73 1861673 8579099
17. Ohtani K Sakamoto H Rutherford T et al Ezrin, a membrane-cytoskeletal linking protein, is highly expressed in atypical endometrial hyperplasia and uterine endometrioid adenocarcinoma Cancer Lett 2002, 179(1):79-86 10.1016/S0304-3835(01)00857-6 11880185
18. Wang LL Biology of osteogenic sarcoma Cancer J 2005, 11(4):294-305 10.1097/00130404-200507000-00005 16197719
19. Makitie T Carpen O Vaheri A Kivela T Ezrin as a prognostic indicator and its relationship to tumor characteristics in uveal malignant melanoma Invest Ophthalmol Vis Sci 2001, 42(11):2442-9 11581181
20. Edmondson HA Steiner PE Primary carcinoma of the liver: A study of 100 cases among 48900 necropsies Cancer 1954, 7:462-503 10.1002/ 1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E 13160935
21. Hunter KW Ezrin, a key component in tumor metastasis Trends Mol Med 2004, 10(5):201-4 10.1016/j.molmed.2004.03.001 15121044
22. Adjei AA Hidalgo M Intracellular signal transduction pathway proteins as targets for cancer therapy J Clin Oncol 2005, 23:5386-5403 10.1200/ JCO.2005.23.648 15983388
23. Parent R Kolippakkam D Booth G Beretta L Mammalian target of rapamycin activation impairs hepatocytic differentiation and targets genes moderating lipid homeostasis and hepatocellular growth Cancer Res 2007, 67(9):4337-4345 10.1158/0008-5472.CAN-06-3640 17483347
24. Yeh CN Lee WC Chen MF Hepatic resection and prognosis for patients with hepatocellular carcinoma larger than 10 cm: Two decades of experience at Chang Gung memorial hospital Ann Surg Oncol 2003, 10(9):1070-6 10.1245/ ASO.2003.03.072 14597446
25. Yeh CN Chen MF Lee WC Jeng LB Prognosis factors of hepatic resection for hepatocellular carcinoma with cirrhosis: Univariate and multivariate analysis J Surg Oncol 2002, 81:195-202 10.1002/jso.10178 12451624
26. Yeh CN Lee WC Chen MF Tsay PK Predictors of long-term disease-free survival after resection of hepatocellular carcinoma: Two decades of experience at Chang Gung Memorial Hospital Ann Surg Oncol 2003, 10(8):916-21 10.1245/ASO.2003.09.012 14527911
27. Poon RTP Fan ST Wong J Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma Ann Surg 2000, 232:10-24 1421103 10862190 10.1097/00000658-200007000-00003